Most cited papers from Intravacc (Netherlands)

Intravacc (Netherlands)

What are the most cited papers from Intravacc (Netherlands)?

The most cited paper from Intravacc (Netherlands) is "Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe" (Sélidji Todagbé Agnandji et al., 2015), with 417 citations. Next come "Outer membrane vesicles as platform vaccine technology" (382) and "Current and next generation influenza vaccines: Formulation and production strategies" (333).

Published TypeFieldAccessCitations

Showing 50 of 62 papers. Every paper with more than 44 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe Sélidji Todagbé Agnandji et al. · New England Journal of Medicine Open access	2 Apr 2015	417
2	Outer membrane vesicles as platform vaccine technology Leo van der Pol, Michiel Stork, Peter van der Ley · Biotechnology Journal Open access	Sep 2015	382
3	Current and next generation influenza vaccines: Formulation and production strategies Peter Christiaan Soema, Ronald Kompier, Jean‐Pierre Amorij et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access	5 Jun 2015	333
4	Bioengineering bacterial outer membrane vesicles as vaccine platform Matthias J. H. Gerritzen, Dirk E. Martens, René H. Wijffels et al. · Biotechnology Advances Open access	15 May 2017	293
5	PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity Ana L Silva, Peter Christiaan Soema, Bram Slütter et al. · Human Vaccines & Immunotherapeutics Open access	11 Jan 2016	256
6	Dissolving Microneedle Patches for Dermal Vaccination Mara Leone, Juha Mönkäre, Joke A. Bouwstra et al. · Pharmaceutical Research Open access	17 Jul 2017	218
7	Buccal and sublingual vaccine delivery Heleen Kraan, Hilde Vrieling, Cecil C. Czerkinsky et al. · Journal of Controlled Release Open access	6 Jun 2014	205
8	Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) Geert P. M. Mommen, Christian Karl Frese, Hugo D. Meiring et al. · Proceedings of the National Academy of Sciences Open access	10 Mar 2014	195
9	Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach Peter Christiaan Soema, Geert-Jan Willems, Wim Jiskoot et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access	4 Jul 2015	154
10	Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects Elena Buelow, Teresita d. J. Bello Gonzalez, Susana Fuentes et al. · Microbiome Open access	27 Jul 2017	136
11	Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder Eynat Dellus-Gur, Mikael H. Elias, Emilia Caselli et al. · Journal of Molecular Biology Open access	22 May 2015	127
12	An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection Peter A. van der Ley, Afshin Zariri, Elly van Riet et al. · Frontiers in Immunology Open access	17 Dec 2021	126
13	Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays Koen van der Maaden, Regina Lüttge, Pieter Jan Vos et al. · Drug Delivery and Translational Research Open access	4 Jun 2015	123
14	Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study Dani Cohen, Jacob Atsmon, Cécile Artaud et al. · The Lancet Infectious Diseases	10 Nov 2020	100
15	Developments in the formulation and delivery of spray dried vaccines Gaurav Kanojia, Rimko ten Have, Peter Christiaan Soema et al. · Human Vaccines & Immunotherapeutics Open access	19 Sep 2017	95
16	Large‐scale production of extracellular vesicles: Report on the “massivEVs” ISEV workshop Lucia Paolini et al. · Journal of Extracellular Biology Open access	Oct 2022	94
17	Layer-by-Layer Assembly of Inactivated Poliovirus and N -Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination Koen van der Maaden, Emine Şekerdağ, P. R. T. Schipper et al. · Langmuir	5 Jul 2015	93
18	SARS-CoV-2 host diversity: An update of natural infections and experimental evidence Md. Golzar Hossain, Aneela Javed, Sharmin Akter et al. · Journal of Microbiology Immunology and Infection Open access	25 Jun 2020	90
19	Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats Koen van der Maaden, Sebastiaan J. Trietsch, Heleen Kraan et al. · Pharmaceutical Research	27 Jan 2014	90
20	The composition and initial evaluation of a grimace scale in ferrets after surgical implantation of a telemetry probe Marsinah L. Reijgwart, Nico J. Schoemaker, Riccardo Pascuzzo et al. · PLoS ONE Open access	13 Nov 2017	87
21	Extended O-GlcNAc on HLA Class-I-Bound Peptides Fabio Marino, Marshall W. Bern, Geert P. M. Mommen et al. · Journal of the American Chemical Society Open access	17 Aug 2015	85
22	Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes Theone C. Kon, Adrian Onu, Laurentiu Berbecila et al. · PLoS ONE Open access	9 Mar 2016	84
23	Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity René H. M. Raeven, Larissa van der Maas, Wichard Tilstra et al. · Journal of Proteome Research Open access	19 May 2015	83
24	Systems vaccinology and big data in the vaccine development chain René H. M. Raeven, Elly van Riet, Hugo D. Meiring et al. · Immunology Open access	14 Oct 2018	82
25	A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity Robert M. F. van der Put, Tae Hee Kim, Catherine Guerreiro et al. · Bioconjugate Chemistry	26 Feb 2016	79
26	Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses René H. M. Raeven, Dedeke Rockx-Brouwer, Gaurav Kanojia et al. · Scientific Reports Open access	30 Apr 2020	78
27	Diphtheria toxoid and N -trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice P. R. T. Schipper, Koen van der Maaden, Vincent Groeneveld et al. · Journal of Controlled Release Open access	11 Jul 2017	72
28	Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response Afshin Zariri, Joep Beskers, Bas van de Waterbeemd et al. · Infection and Immunity Open access	Aug 2016	72
29	Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity Geert P. M. Mommen, Fabio Marino, Hugo D. Meiring et al. · Molecular & Cellular Proteomics Open access	13 Jan 2016	72
30	A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine Gaurav Kanojia, Geert-Jan Willems, Henderik Willem Frijlink et al. · International Journal of Pharmaceutics Open access	12 Aug 2016	69
31	Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis Bas van de Waterbeemd, G. Zomer, Patricia Kaaijk et al. · PLoS ONE Open access	31 May 2013	69
32	Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines Bas van de Waterbeemd, Geert P. M. Mommen, Jeroen L. A. Pennings et al. · Journal of Proteome Research Open access	15 Feb 2013	67
33	Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules Celia R. Berkers, Annemieke de Jong, Karianne G. Schuurman et al. · The Journal of Immunology Open access	24 Sep 2015	67
34	Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines Geert G Leroux-Roels, Isabel Leroux‐Roels, Frédéric Clément et al. · Human Vaccines & Immunotherapeutics Open access	24 Jun 2014	67
35	Development of inactivated poliovirus vaccine from Sabin strains: A progress report Hiromasa Okayasu, Carolyn Sein, Ahd Hamidi et al. · Biologicals	9 Oct 2016	66
36	Neutralizing Antibodies Elicited by a Novel Detoxified Pneumolysin Derivative, PlyD1, Provide Protection against Both Pneumococcal Infection and Lung Injury Danielle Salha, Jason Szeto, Lisa E. Myers et al. · Infection and Immunity Open access	3 Apr 2012	65
37	Deletion of accessory genes 3a, 3b, 5a or 5b from avian coronavirus infectious bronchitis virus induces an attenuated phenotype both in vitro and in vivo Andrea Laconi, Steven J. van Beurden, Alinda J. Berends et al. · Journal of General Virology Open access	Aug 2018	64
38	Biosynthetically engineered lipopolysaccharide as vaccine adjuvant Afshin Zariri, Peter van der Ley · Expert Review of Vaccines	22 Mar 2015	64
39	Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment Mara Leone, Marjolein I. Priester, Stefan G. Romeijn et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access	16 Nov 2018	63
40	Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification Matthias J. H. Gerritzen, Merijn L.M. Salverda, Dirk E. Martens et al. · Vaccine Open access	2 Aug 2019	61
41	High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis Matthias J. H. Gerritzen, Ronald H. W. Maas, Jan van den IJssel et al. · Microbial Cell Factories Open access	3 Oct 2018	61
42	Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars Wouter F. Tonnis, Jean‐Pierre Amorij, M.A. Vreeman et al. · European Journal of Pharmaceutical Sciences Open access	25 Jan 2014	59
43	Universal Applicator for Digitally-Controlled Pressing Force and Impact Velocity Insertion of Microneedles into Skin Mara Leone, Bart H. Van Oorschot, M. Reza Nejadnik et al. · Pharmaceutics Open access	Nov 2018	58
44	Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities Arnoud M. Akkermans et al. · Biologicals Open access	8 Oct 2020	57
45	The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo Rob J. Vandebriel, Jolanda P. Vermeulen, Laurens B. van Engelen et al. · Particle and Fibre Toxicology Open access	30 Jan 2018	57
46	Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome Ingrid M. M. Schellens, Ilka Hoof, Hugo D. Meiring et al. · PLoS ONE Open access	16 Sep 2015	57
47	Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies Agnese Donadei, Heleen Kraan, Olga J.A.E Ophorst et al. · Journal of Controlled Release	Sep 2019	56
48	Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals Yvonne E. Thomassen, Aart G. van ’t Oever, Monique G.C.T. van Oijen et al. · PLoS ONE Open access	12 Dec 2013	54
49	Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses Peter Christiaan Soema, Elly van Riet, Gideon F. A. Kersten et al. · Frontiers in Immunology Open access	15 May 2015	54
50	Combatting infectious diseases; nanotechnology as a platform for rational vaccine design Elly van Riet, Akira Ainai, Tadaki Suzuki et al. · Advanced Drug Delivery Reviews ReviewOpen access	23 May 2014	53

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.